MedTrace Logo

The Effect of Progressive Relaxation Exercises With Therapeutic Clown

NCT07525388 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 162

Last updated 2026-04-13

No results posted yet for this study

Summary

This study was conducted to investigate the effects of progressive relaxation exercises, performed with the assistance of a therapeutic clown during the pre-operative period, on fear, anxiety and physiological parameters in children. This randomised controlled trial included children aged 6-10 years undergoing circumcision surgery. The children were randomised into three groups: a progressive relaxation exercise group led by a therapeutic clown, a progressive relaxation group led by a nurse, and a control group. Fear, anxiety and physiological parameters (heart rate, respiratory rate, blood pressure, oxygen saturation) were assessed before and after the procedure.

Conditions

  • Therapeutic Clown
  • Relaxation Exercise
  • Anxiety
  • Fear
  • Surgery

Interventions

OTHER

Relaxation exercise group led by a therapeutic clown

Relaxation exercises help to reduce psychological pressure and tension in individuals by highlighting the difference between relaxation and tension. The therapeutic clown facilitates the release of endorphins, thereby promoting relaxation in situations that cause psychological tension. The combination of the two can create a synergistic effect.

OTHER

The relaxation exercise group led by a research nurse

Relaxation exercises help to reduce psychological pressure and tension in individuals by highlighting the difference between relaxation and muscle tension.

Sponsors & Collaborators

  • Ataturk University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
10 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-25
Primary Completion
2026-04-01
Completion
2026-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07525388 on ClinicalTrials.gov